{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:02:09Z","timestamp":1792270929724,"version":"4.4.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,21]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Increased serum glucose variability has been proposed as a risk factor for perioperative morbidity and mortality. Given the greater surgical complexity and complication risk of revision total joint arthroplasty (TJA), previous findings may not be generalizable to the revision population. The purpose of this study was to investigate the association between glucose variability and postoperative complications following aseptic revision TJA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We identified 1,983 patients who underwent an aseptic revision TJA (636 total knee arthroplasties [TKAs] and 1,347 total hip arthroplasties [THAs]) from 2001 to 2019. Patients with \u22652 postoperative glucose values per day or \u22653 values during hospitalization were included in this study. Glucose variability was assessed using the coefficient of variation (COV). Outcomes included length of hospital stay, 90-day complications, mortality, and periprosthetic joint infection (PJI) as defined by the 2018 International Consensus Meeting criteria. Multivariate regression was used to determine the association between glucose variability and each end point, using COV as continuous and categorical variables (that is, COV tertiles).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Patients with high glycemic variability were at 1.7 times greater risk for 90-day complications (odds ratio [OR], 1.664 [95% confidence interval (CI), 1.266 to 2.188]; p &lt; 0.001) and 2 times greater risk for PJI at a minimum 1-year follow-up (OR, 1.984 [95% CI, 1.270 to 3.100]; p = 0.003). The risk of 90-day complications increased by 2.2% (OR, 1.022 [95% CI, 1.012 to 1.032]; p &lt; 0.001) and the risk of PJI increased by 1.8% (OR, 1.018 [95% CI, 1.003 to 1.034]; p = 0.013) for every percentage-point increase in COV. Patients with higher glucose variability also had a longer length of stay (beta, 1.028 days [95% CI, 0.590 to 1.466 days]; p &lt; 0.001). These associations were independent of age, sex, body mass index, Charlson Comorbidity Index, involved joint, operative time, history of diabetes, and mean glucose levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Higher glucose variability was associated with an increased risk of medical complications and PJI following aseptic revision TJA. Patients undergoing these complex procedures should have glucose levels monitored closely in the perioperative period. Future studies should evaluate the utility of continuous glucose monitoring in this high-risk population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Prognostic\n                      <jats:underline>Level III<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.21.00878","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T08:00:37Z","timestamp":1658563237000},"page":"1614-1620","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Serum Glucose Variability Increases the Risk of Complications Following Aseptic Revision Hip and Knee Arthroplasty"],"prefix":"10.2106","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7337-3321","authenticated-orcid":false,"given":"Graham S.","family":"Goh","sequence":"first","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Shohat","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2250-2629","authenticated-orcid":false,"given":"Mohammad S.","family":"Abdelaal","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Small","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-2682","authenticated-orcid":false,"given":"Terence","family":"Thomas","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri-Anne","family":"Ciesielka","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-5870","authenticated-orcid":false,"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[{"name":"Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"issue":"3","key":"bib1-20260212","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.arth.2014.10.009","article-title":"Diabetes mellitus, hyperglycemia, hemoglobin A1C and the risk of prosthetic joint infections in total hip and knee arthroplasty","volume":"30","author":"Maradit Kremers","year":"2015","journal-title":"J Arthroplasty."},{"issue":"14","key":"bib2-20260212","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.295.14.1707","article-title":"Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications","volume":"295","author":"Brownlee","year":"2006","journal-title":"JAMA."},{"issue":"4","key":"bib3-20260212","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00134-010-2129-5","article-title":"Glucose variability measures and their effect on mortality: a systematic review","volume":"37","author":"Eslami","year":"2011","journal-title":"Intensive Care Med."},{"issue":"6865","key":"bib4-20260212","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature."},{"issue":"2","key":"bib5-20260212","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.atherosclerosis.2005.03.015","article-title":"Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production","volume":"183","author":"Quagliaro","year":"2005","journal-title":"Atherosclerosis."},{"issue":"14","key":"bib6-20260212","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA."},{"issue":"15","key":"bib7-20260212","doi-asserted-by":"crossref","first-page":"7783","DOI":"10.3390\/ijms22157783","article-title":"Glucose Variability: how does it work?","volume":"22","author":"Klimontov","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"16","key":"bib8-20260212","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress","volume":"106","author":"Esposito","year":"2002","journal-title":"Circulation."},{"issue":"6","key":"bib9-20260212","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.sla.0000220041.68156.67","article-title":"Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms","volume":"243","author":"Turina","year":"2006","journal-title":"Ann Surg."},{"issue":"12","key":"bib10-20260212","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.2337\/dc12-2430","article-title":"Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients","volume":"36","author":"Mendez","year":"2013","journal-title":"Diabetes Care."},{"issue":"7","key":"bib11-20260212","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1210\/jc.2017-00450","article-title":"High glucose variability increases mortality risk in hospitalized patients","volume":"102","author":"Akirov","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"bib12-20260212","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2009-0021","article-title":"Glucose variability; does it matter?","volume":"31","author":"Siegelaar","year":"2010","journal-title":"Endocr Rev."},{"issue":"4","key":"bib13-20260212","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4093\/dmj.2015.39.4.273","article-title":"Glycemic variability: how do we measure it and why is it important?","volume":"39","author":"Suh","year":"2015","journal-title":"Diabetes Metab J."},{"issue":"2","key":"bib14-20260212","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00000542-200608000-00006","article-title":"Variability of blood glucose concentration and short-term mortality in critically ill patients","volume":"105","author":"Egi","year":"2006","journal-title":"Anesthesiology."},{"issue":"13","key":"bib15-20260212","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2106\/JBJS.17.00798","article-title":"Increased postoperative glucose variability is associated with adverse outcomes following total joint arthroplasty","volume":"100","author":"Shohat","year":"2018","journal-title":"J Bone Joint Surg Am."},{"issue":"5","key":"bib16-20260212","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.arth.2019.11.046","article-title":"Increased postoperative glucose variability is associated with adverse outcome following two-stage exchange arthroplasty for periprosthetic joint infection","volume":"35","author":"Wang","year":"2020","journal-title":"J Arthroplasty."},{"issue":"3","key":"bib17-20260212","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.arth.2015.09.033","article-title":"How much do adverse event rates differ between primary and revision total joint arthroplasty?","volume":"31","author":"Bohl","year":"2016","journal-title":"J Arthroplasty."},{"issue":"9","key":"bib18-20260212","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.arth.2017.03.066","article-title":"Current epidemiology of revision total knee arthroplasty in the United States","volume":"32","author":"Delanois","year":"2017","journal-title":"J Arthroplasty."},{"issue":"5","key":"bib19-20260212","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.arth.2018.02.078","article-title":"The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria","volume":"33","author":"Parvizi","year":"2018","journal-title":"J Arthroplasty."},{"issue":"7","key":"bib20-20260212","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.2337\/dc09-0076","article-title":"Reference values for continuous glucose monitoring in Chinese subjects","volume":"32","author":"Zhou","year":"2009","journal-title":"Diabetes Care."},{"issue":"6","key":"bib21-20260212","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2337\/dc09-1971","article-title":"Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals","volume":"33","author":"Fox","year":"2010","journal-title":"Diabetes Care."},{"issue":"8","key":"bib22-20260212","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.arth.2019.04.062","article-title":"A Nurse Navigator program is effective in reducing episode-of-care costs following primary hip and knee arthroplasty","volume":"34","author":"Phillips","year":"2019","journal-title":"J Arthroplasty."},{"issue":"3","key":"bib23-20260212","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejim.2010.02.006","article-title":"Preoperative hyperglycemia predicts infected total knee replacement","volume":"21","author":"J\u00e4msen","year":"2010","journal-title":"Eur J Intern Med."},{"issue":"2","key":"bib24-20260212","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/193229681100500231","article-title":"Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty","volume":"5","author":"Mraovic","year":"2011","journal-title":"J Diabetes Sci Technol."},{"issue":"7","key":"bib25-20260212","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.arth.2015.01.040","article-title":"Is hemoglobin A1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty?","volume":"30","author":"Chrastil","year":"2015","journal-title":"J Arthroplasty."},{"issue":"8","key":"bib26-20260212","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1302\/0301-620X.100B8.BJJ-2017-1283.R1","article-title":"Increased postoperative glucose variability is associated with adverse outcomes following orthopaedic surgery","volume":"100-B","author":"Shohat","year":"2018","journal-title":"Bone Joint J."},{"issue":"10","key":"bib27-20260212","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1007\/s00167-020-06154-7","article-title":"The projected volume of primary and revision total knee arthroplasty will place an immense burden on future health care systems over the next 30 years","volume":"29","author":"Klug","year":"2021","journal-title":"Knee Surg Sports Traumatol Arthrosc."},{"issue":"3","key":"bib28-20260212","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/ALN.0000000000001515","article-title":"Perioperative hyperglycemia management: an update","volume":"126","author":"Duggan","year":"2017","journal-title":"Anesthesiology."},{"issue":"9","key":"bib29-20260212","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/diacare.22.9.1408","article-title":"Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes","volume":"22","author":"Golden","year":"1999","journal-title":"Diabetes Care."},{"issue":"5","key":"bib30-20260212","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/SLA.0000000000002323","article-title":"Effect of preoperative diabetes management on glycemic control and clinical outcomes after elective surgery","volume":"267","author":"Garg","year":"2018","journal-title":"Ann Surg."},{"issue":"Suppl 1","key":"bib31-20260212","first-page":"59","article-title":"Relationship between glycemic Lability Index, infections and outcome in critically ill patients [abstract]","volume":"16","author":"Donati","year":"2012","journal-title":"Crit Care."},{"issue":"3","key":"bib32-20260212","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.diabres.2013.11.026","article-title":"Impact of glycemic variability and hypoglycemia on adverse hospital outcomes in non-critically ill patients","volume":"103","author":"Kim","year":"2014","journal-title":"Diabetes Res Clin Pract."},{"issue":"2","key":"bib33-20260212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1213\/ANE.0000000000000100","article-title":"Increased glycemic variability in patients with elevated preoperative HbA1C predicts adverse outcomes following coronary artery bypass grafting surgery","volume":"118","author":"Subramaniam","year":"2014","journal-title":"Anesth Analg."},{"issue":"9","key":"bib34-20260212","first-page":"e0183894","article-title":"Range of glucose as a glycemic variability and 3-month outcome in diabetic patients with acute ischemic stroke","volume":"12","author":"Kim","year":"2017"},{"issue":"2","key":"bib35-20260212","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/qjmed\/hcy235","article-title":"High blood glucose variability is associated with bacteremia and mortality in patients hospitalized with acute infection","volume":"112","author":"Atamna","year":"2019","journal-title":"QJM."},{"issue":"8","key":"bib36-20260212","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1464-5491.2010.02967.x","article-title":"\u2018Glycaemic variability\u2019: a new therapeutic challenge in diabetes and the critical care setting","volume":"27","author":"Ceriello","year":"2010","journal-title":"Diabet Med."},{"issue":"5","key":"bib37-20260212","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00125-011-2049-0","article-title":"Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells","volume":"54","author":"Schisano","year":"2011","journal-title":"Diabetologia."},{"issue":"2","key":"bib38-20260212","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2337\/dc09-1343","article-title":"Bariatric surgery reduces oxidative stress by blunting 24-h acute glucose fluctuations in type 2 diabetic obese patients","volume":"33","author":"Marfella","year":"2010","journal-title":"Diabetes Care."},{"issue":"7","key":"bib39-20260212","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.arth.2005.04.021","article-title":"Differences in patient and procedure characteristics and hospital resource use in primary and revision total joint arthroplasty: a multicenter study","volume":"20","author":"Bozic","year":"2005","journal-title":"J Arthroplasty."},{"issue":"3","key":"bib40-20260212","first-page":"526","article-title":"Incidence and short-term outcomes of primary and revision hip replacement in the United States","volume":"89","author":"Zhan","year":"2007"},{"issue":"11","key":"bib41-20260212","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1007\/s11999-010-1399-0","article-title":"Risk of subsequent revision after primary and revision total joint arthroplasty","volume":"468","author":"Ong","year":"2010","journal-title":"Clin Orthop Relat Res."},{"issue":"3","key":"bib42-20260212","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2106\/00004623-200503000-00014","article-title":"Hospital resource utilization for primary and revision total hip arthroplasty","volume":"87","author":"Bozic","year":"2005","journal-title":"J Bone Joint Surg Am."},{"issue":"24","key":"bib43-20260212","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2106\/JBJS.L.00789","article-title":"Periprosthetic joint infection increases the risk of one-year mortality","volume":"95","author":"Zmistowski","year":"2013","journal-title":"J Bone Joint Surg Am."},{"issue":"5","key":"bib44-20260212","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00264-013-2265-y","article-title":"Periprosthetic joint infection\u2014effect on quality of life","volume":"38","author":"Helwig","year":"2014","journal-title":"Int Orthop."},{"issue":"Suppl 2","key":"bib45-20260212","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.injury.2014.04.002","article-title":"Delayed union and nonunions: epidemiology, clinical issues, and financial aspects","volume":"45","author":"Hak","year":"2014","journal-title":"Injury."},{"issue":"8","key":"bib46-20260212","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.arth.2017.03.027","article-title":"Effect of bundled payments and health care reform as alternative payment models in total joint arthroplasty: a clinical review","volume":"32","author":"Siddiqi","year":"2017","journal-title":"J Arthroplasty."},{"issue":"4","key":"bib47-20260212","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1932296819826111","article-title":"Glycemic variability: risk factors, assessment, and control","volume":"13","author":"Kovatchev","year":"2019","journal-title":"J Diabetes Sci Technol."},{"issue":"1","key":"bib48-20260212","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12933-020-01085-6","article-title":"Glycemic variability: adverse clinical outcomes and how to improve it?","volume":"19","author":"Zhou","year":"2020","journal-title":"Cardiovasc Diabetol."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.21.00878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:55:02Z","timestamp":1787752502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.21.00878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":48,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.21.00878","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]}}}